The size of the Breast Imaging Market in the Middle East & Africa was valued at USD 0.26 Billion in 2021 and is expected to be worth USD 0.32 Billion by 2025, growing at a CAGR of 7.47 % CAGR during the forecast period.
The breast imaging market in the MEA region is expected to be driven by the growing prevalence of breast cancer primarily. As breast cancer is one of the most frequent cancers among women, for instance, in 2021, many new cases have been increased, increasing the demand for breast imaging in the MEA market. In addition, the technological advancements for developing advanced diagnosing devices and treatments, rising awareness about breast cancer among the people by organizing several programs, seminars, and pre- diagnosing benefits of breast cancer are projected to propel the breast imaging market. On the other hand, the growing initiatives for developing advanced and well-equipped health care infrastructure in the region for providing greater accessibility to the health care supplements and the growing urbanization are also propelling the market growth.
Furthermore, an increase in the investments and fundings from government and non-government organizations in research and development activities for manufacturing various kinds of therapies and innovative products is expected to provide lucrative growth opportunities to the market growth.
However, an increase in the cost of breast imaging systems and a lack of skilled and trained professionals for maintaining and operating the systems is majorly restraining the growth of breast imaging in the MEA market. In addition, the installation and maintenance costs of the system are very expensive. Also, the technological advancements for developing advanced diagnosing devices are restraining the market growth. Furthermore, the presence of some side effects and health issues the patients face from being exposed to radiation also hamper the growth of breast imaging in the market.
This research report on the MEA breast imaging market has been segmented and sub-segmented into the following categories:
The Middle East and Africa market is anticipated to record a moderate share in the global breast imaging market during the forecast period. The market growth is projected to be fuelled by an increase in the prevalence of breast cancer among females and males, improving healthcare sectors, and supportive government policies. Furthermore, the emerging countries in the region such as South Africa, UAE, and Saudi Arabia significantly contribute to the MEA regional market growth.
The UAE breast imaging market is expected to hold a significant amount of share in the MEA market due to increase in the growing cases of breast cancer in the region as; for instance, according to World Health Organization (WHO), there were 684,996 fatalities due to breast cancer in 2020 and 2021 it is estimated that due to breast cancer there will be 43,600 fatalities in women and 530 fatalities in men. In addition, the increase in technological advancements for developing advanced devices and treatments is increasing the market growth.
Similarly, the South African breast imaging market is estimated to hold a promising share in the MEA market due to increased investments from government and non-government organizations into rigorous research and development activities and enriching the market growth of breast imaging.
On the other hand, the Saudi Arabian breast imaging market is estimated to witness a significant share in the MEA market during the forecast period. The increase in the government initiatives for developing advanced healthcare infrastructure with the growing awareness about breast cancer among the people contributes to the market growth.
KEY MARKET PLAYERS:
A few of the prominent companies operating in the Middle East & Africa breast imaging market profiled in the report are Hologic, Inc., GE Healthcare, Siemens Healthcare, Philips Healthcare, Fujifilm Holdings Corporation, Gamma Medica, Inc., Toshiba Corporation, Sonocine, Inc., Aurora Imaging Technology, Inc., and Dilon Technologies, Inc.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Ionizing Technologies
188.8.131.52 Digital Mammography
184.108.40.206 3D Mammography
220.127.116.11 Molecular Breast-Specific Gamma Imaging (MBI/BSGI)
18.104.22.168 Positron Emission Tomography and Computed Tomography (PET-CT)
22.214.171.124 Cone-Beam Computed Tomography (CBCT)
126.96.36.199 Positron Emission Mammography (PEM)
5.1.3 Non-ionizing Technologies
188.8.131.52 Breast MRI
184.108.40.206 Breast Ultrasound
220.127.116.11 Automated Whole-Breast Ultrasound (AWBU)
18.104.22.168 Breast Thermography
22.214.171.124 Optical Imaging
5.1.4 Y-o-Y Growth Analysis, By Type
5.1.5 Market Attractiveness Analysis, By Type
5.1.6 Market Share Analysis, By Type
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
126.96.36.199 By Geographical Area
188.8.131.52 By Type
6.1.4 Market Attractiveness Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Type
6.1.5 Market Share Analysis
18.104.22.168 By Geographical Area
22.214.171.124 By Type
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Hologic Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 Siemens Healthcare
8.4 Philips Healthcare
8.5 Fujifilm Holdings Corporation Gamma Medica Inc.
8.6 Toshiba Corporation
8.7 Sonocine Inc.
8.8 Aurora Imaging Technolog Inc.,
8.9 Dilon Technologies, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures